NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  European Journal of Pharmacology

• Publication date

  1996-03-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(95)00837-3PMID 8901010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats

  2005cited by this paper
• A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice

  2005cited by this paper
• Dendro-dendritic synapses in substantia nigra: Descriptions based on analysis of serial sections

  2004cited by this paper
• Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease

  1995cited by this paper
• Modulation of dopamine D1‐mediated turning behavior and striatal c‐fos expression by the substantia nigra

  1995cited by this paper
• Role of D1 receptor mechanisms in the potentiation of motor responses to L-DOPA and apomorphine by MK 801 in the reserpine-treated mouse

  1994cited by this paper
• PCP site 2: a high affinity MK-801-insensitive phencyclidine binding site.

  1994cited by this paper
• Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model.

  1994cited by this paper
• Aromatic L‐Amino Acid Decarboxylase Activity of Mouse Striatum Is Modulated via Dopamine Receptors

  1993cited by this paper
• Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine

  1993cited by this paper
• Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic midbrain neurons.

  1993cited by this paper
• Dopamine formation from L-dopa administered exogenously is independent of dopaminergic neuronal activity: studies with in vivo microdialysis.

  1993cited by this paper
• Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse.

  1993cited by this paper
• Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.

  1993cited by this paper
• Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons.

  1992cited by this paper
• Regulation of Aromatic l‐Amino Acid Decarboxylase by Dopamine Receptors in the Rat Brain

  1992cited by this paper
• Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801

  1992cited by this paper
• Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis.

  1992cited by this paper
• Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.

  1992cited by this paper
• MK‐801 Increases Extracellular 5‐Hydroxytryptamine in Rat Hippocampus and Striatum In Vivo

  1992cited by this paper
• Regional Effects of Sodium Valproate on Extracellular Concentrations of 5‐Hydroxytryptamine, Dopamine, and Their Metabolites in the Rat Brain: An In Vivo Microdialysis Study

  1992cited by this paper
• Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat.

  1992cited by this paper
• Presynaptic Adenosine A2 and N‐Methyl‐D‐Aspartate Receptors Regulate Dopamine Synthesis in Rat Striatal Synaptosomes

  1991cited by this paper
• A Comparison of Axonal and Somatodendritic Dopamine Release Using In Vivo Dialysis

  1991cited by this paper
• Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats

  1991cited by this paper
• Characterization and Pharmacological Responsiveness of Dopamine Release Recorded by Microdialysis in the Substantia Nigra of Conscious Rats

  1991cited by this paper
• Reserpine-insensitive dopamine release in the substantia nigra?

  1991cited by this paper
• Differential Interaction of Phencyclidine‐Like Drugs with the Dopamine Uptake Complex In Vivo

  1991cited by this paper
• Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.

  1990cited by this paper
• NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats

  1990cited by this paper
• Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches.

  1990cited by this paper
• In Vivo Mechanisms Underlying Dopamine Release from Rat Nigrostriatal Terminals: II. Studies Using Potassium and Tyramine

  1990cited by this paper
• Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum

  1989cited by this paper
• Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms

  1989cited by this paper
• What causes membrane fusion in exocytosis?

  1989cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper
• Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

  1987cited by this paper
• D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.

  1987cited by this paper
• The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem

  1986cited by this paper
• Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra

  1985cited by this paper
• Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration.

  1981cited by this paper
• The effect of blocking dopamine release on synthesis rate of dopamine in the striatum of the rat.

  1975cited by this paper
• Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment.

  1970cited by this paper

• Sex and strain differences in dynamic and static properties of the mesolimbic dopamine system

  2020cites this paper
• Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction among Glutamate, Dopamine, and GABA

  2019cites this paper
• Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice.

  2014cites this paper
• Dopamine D(2)/D(3) receptor binding of [(123)I]epidepride in risperidone-treatment chronic MK-801-induced rat schizophrenia model using nanoSPECT/CT neuroimaging.

  2014cites this paper
• The cognitive profiling of the methylazoxymethanol acetate model of schizophrenia

  2013cites this paper
• [123I]Epidepride neuroimaging of dopamine D2/D3 receptor in chronic MK-801-induced rat schizophrenia model.

  2012cites this paper
• MK-801-induced rat schizophrenia model

  2012cites this paper
• N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.

  2012cites this paper
• Motor actions of eliprodil in the normal and monoamine-depleted mouse: A role in the treatment of Parkinson's disease?

  2005cites this paper
• Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase

  2005cites this paper
• Effects of alpha-methyl-p-tyrosine on extracellular dopamine levels in the nucleus accumbens and the dorsal striatum of freely moving rats.

  2005cites this paper
• The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems.

  2004cites this paper
• Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice.

  2002cites this paper
• Dextromethorphan increases tyrosine hydroxylase mRNA in the mesencephalon of adolescent rats.

  2001cites this paper
• The regulation of NMDA-evoked dopamine release by nitric oxide in the frontal cortex and raphe nuclei of the freely moving rat.

  2001cites this paper
• Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine.

  2001cites this paper
• Effects of dextromethorphan treated at adolescent on behavior and neurochemistry in rats

  2001cites this paper
• MK801 influences L-DOPA-induced dopamine release in intact and hemi-parkinson rats.

  2000cites this paper
• Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain.

  2000cites this paper
• Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.

  1999cites this paper
• Involvement of basal ganglia transmitter systems in movement initiation.

  1998cites this paper
• Reciprocal dopamine-glutamate modulation of release in the basal ganglia.

  1998cites this paper
• Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.

  1998cites this paper
• Review Article Reciprocaldopamine-glutamatemodulation of release in the basalganglia

  1998cites this paper
• Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat.

  1998cites this paper
• Biotransformation of l‐DOPA to Dopamine in the Substantia Nigra of Freely Moving Rats: Effect of Dopamine Receptor Agonists and Antagonists

  1998cites this paper
• Experimental Models of Parkinson's Disease: From the Static to the Dynamic

  1998cites this paper
• The antiparkinsonian drug budipine stimulates the activity of aromatic L‐amino acid decarboxylase and enhances L‐DOPA‐induced dopamine release in rat substantia nigra

  1998cites this paper
• Glutamatergic control over brain dopamine release in vivo and in vitro.

  1997cites this paper
• Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra.

  1997cites this paper
• Motor effects of lamotrigine in naive and dopamine-depleted mice.

  1996cites this paper